What is the best treatment for patients after treatment for bile duct stones?
This study, called ROSIER, aims to find the best treatment for patients after gallstones have been cleared from their bile duct. While surgery to remove the gallbladder is often suggested, not everyone has it. We want to understand if having the gallbladder removed after this procedure truly helps prevent future problems or if it's better to simply monitor patients without surgery. Participants will be randomly put into two groups: one will have their gallbladder removed, and the other will not have surgery but will be monitored. We'll follow everyone for two years to see which approach works best. This research could help doctors make clearer recommendations and improve care for many people in the UK.
At a glance
What is this study about?
This study, called ROSIER, is looking into the best way to care for people after they've had gallstones removed from their bile duct. Gallstones are small, hard lumps that can form in a small organ called the gallbladder, which sits under your liver. Sometimes, these stones can move into the bile duct, a tube that carries digestive fluids. When this happens, it can cause pain and other serious problems.
About 20,000 people in England each year have a procedure to clear these stones from their bile duct. After this, doctors often suggest removing the gallbladder to stop new gallstones forming or causing problems. However, not everyone has this surgery – in fact, about half of those who could have it don't. This means some people might be having unnecessary surgery, while others might not be getting the full treatment they need. The ROSIER study aims to collect strong evidence to decide which approach is truly best for patients in the long run.
By comparing what happens to people who have their gallbladder removed with those who don't, we hope to understand if the surgery really improves health and prevents problems. The findings from this study could help doctors across the UK give clearer advice and better care to patients dealing with gallstones.
Key takeaways
- This study compares two ways to manage gallstones after they've been cleared from the bile duct.
- It aims to find out if removing the gallbladder after treatment helps prevent future problems.
- Participants will be randomly assigned to either have gallbladder surgery or be monitored without surgery.
- The study will follow participants for two years, collecting health and quality of life information.
- Your participation could help improve care for many people in the UK with gallstones.
- You are free to leave the study at any time.
Who may be eligible?
You might be able to take part in this study if you are an adult, aged 18 or over. You must have recently had gallstones cleared from your bile duct.
It’s also important that you are generally well enough to have an operation to remove your gallbladder, should you be placed in that group. You should also be willing to follow the study plan, including filling out questionnaires.
However, you cannot take part if you are pregnant or planning to become so. You also can’t join if you have a serious gallbladder infection, have had a tube placed into your gallbladder, or have already had your gallbladder removed.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you 18 years old or older?
- Have you recently had gallstones cleared from your bile duct?
- Are you generally well enough to have gallbladder surgery, if needed?
- Are you willing to fill out questionnaires during the study?
- Are you not pregnant or planning to become so?
What does participation involve?
If you decide to take part in the ROSIER study, you will be randomly assigned to one of two groups, like flipping a coin. One group will have surgery to remove their gallbladder. The other group will not have this surgery but will be carefully monitored by their healthcare team, with no plans for their gallbladder to be removed.
Regardless of which group you are in, we will follow your progress for two years from when you join the study. We will collect information about your health when you start, and then at 3, 6, 12, and 24 months afterwards. You will also be asked to fill out short questionnaires about your quality of life every three months for two years, and a very short monthly questionnaire about any pain you might experience. Some health information will also be collected from your standard NHS hospital records.
Potential risks and benefits
Locations (17)
- Leeds Teaching Hospitals NHS TrustCity onlyLeeds, United Kingdom
- University of LeedsApproximateLeeds, United Kingdom
- University Hospital Southampton NHS Foundation TrustCity onlySouthampton, United Kingdom
- Somerset NHS Foundation TrustCity onlyTaunton, United Kingdom
- University Hospitals Plymouth NHS TrustCity onlyPlymouth, United Kingdom
- Hampshire Hospitals NHS Foundation TrustUnverifiedBasingstoke, United Kingdom
- University Hospitals of Derby and Burton NHS Foundation TrustUnverifiedDerby, United Kingdom
- The Newcastle upon Tyne Hospitals NHS Foundation TrustUnverifiedNewcastle upon Tyne, United Kingdom
- Hull University Teaching Hospitals NHS TrustUnverifiedHull, United Kingdom
- Bradford Teaching Hospitals NHS Foundation TrustUnverifiedBradford, United Kingdom
- East Suffolk and North Essex NHS Foundation TrustUnverifiedColchester, United Kingdom
- North Bristol NHS TrustUnverifiedBristol, United Kingdom
Common questions
What are common bile duct stones?
These are gallstones that have moved from the gallbladder into the bile duct, a tube that carries digestive fluids. They can cause pain and other health problems.
What is an ERCP?
ERCP stands for Endoscopic Retrograde Cholangiopancreatography. It's a procedure where doctors use a thin, flexible tube with a camera to see inside and remove stones from your bile duct.
What does being 'randomly assigned' mean?
It means you'll be put into one of the two study groups by chance, like drawing names from a hat. Neither you nor your doctor can choose which group you're in.
How long will I be involved in the study?
If you join the study, you'll be followed for two years from the time you start.
Who is paying for this study?
The study is funded by the National Institute for Health and Care Research (NIHR), which is a major funder of health research in the UK.
How to find out more
Rachel Kelly
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.